![]() |
Volumn 23, Issue 4, 2012, Pages 743-754
|
Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIINFECTIVE AGENT;
CEFOTAXIME;
HEPARIN;
ADULT;
AGED;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
CATHETER INFECTION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
ISOLATION AND PURIFICATION;
KAPLAN MEIER METHOD;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
NOSE MUCOSA;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STAPHYLOCOCCUS AUREUS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
ANTICOAGULANTS;
CATHETER-RELATED INFECTIONS;
CEFOTAXIME;
FEMALE;
HEPARIN;
HUMANS;
KAPLAN-MEIER ESTIMATE;
MALE;
MIDDLE AGED;
NASAL MUCOSA;
PROSPECTIVE STUDIES;
STAPHYLOCOCCUS AUREUS;
|
EID: 84865591878
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: 10.4103/1319-2442.98154 Document Type: Article |
Times cited : (16)
|
References (0)
|